Who has invested in RVAC Medicines?

CBC Group, Pavilion Capital, EDBI, GS Holdings are named among the investors backing RVAC Medicines.

RVAC Medicines Funding: $170M Raised, Investors & Rounds

RVAC Medicines funding overview

RVAC Medicines is based in Singapore, Singapore. RVAC Medicines has raised $170M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for RVAC Medicines runs through 2022; nothing later has been disclosed. Investors on record include CBC Group, Pavilion Capital, EDBI, GS Holdings. 4 distinct backers are named across the disclosed rounds.

RVAC Medicines at a glance

Total raised: $170M
Latest round date: April 2022
Headquarters: Singapore, Singapore
Notable investors: CBC Group, Pavilion Capital, EDBI, GS Holdings

Frequently asked about RVAC Medicines funding

How much has RVAC Medicines raised?: RVAC Medicines has raised $170M in total disclosed funding across the rounds on record.
Who has invested in RVAC Medicines?: CBC Group, Pavilion Capital, EDBI, GS Holdings are named among the investors backing RVAC Medicines.
What was the latest RVAC Medicines funding round?: No round stage has been disclosed for RVAC Medicines.
Where is RVAC Medicines based?: RVAC Medicines is based in Singapore, Singapore.
When did RVAC Medicines last raise?: The last disclosed RVAC Medicines round closed in April 2022.

Totals shown for RVAC Medicines aggregate every disclosed round on file. To see how that compares, browse the companies in Singapore and the investors behind them below.

RVAC Medicines Funding: $170M Raised, Investors & Rounds

RVAC Medicines funding overview

RVAC Medicines at a glance

Frequently asked about RVAC Medicines funding

Companies related to RVAC Medicines (24)

Browse related funding lists (6)